Interestingly, the level of LILRA2 expression is significantly higher in patients with lepromatous leprosy, a disease characterized by Th2 biased immune response leading to severe inflammation but poor bacterial killing as compared to tuberculoid leprosy, which is characterized by Th1 biased response with minimal inflammation but efficient bacterial killing [9]. This evidence concerns the gene LILRA2 and tuberculoid leprosy.